US › Healthcare

Goodrx Holdings Inc (GDRX)

US · Healthcare · Health Information Services

$3.34+5.70%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$194.0M
Revenue YoY
-4.4%
Net profit
$1.2M
Profit YoY
-89.4%
EPS
$0.07
EPS estimate
$0.07
Net margin
0.6%

EPS came in at 0.07 against a street estimate of 0.07 — a beat of 0.0%.

Key statistics

Market cap
$1.04B
P/E
51.2
Forward P/E
5.4
P/B
1.67
Book value
$1.84
EPS (TTM)
$0.06
52-week high
$5.81
52-week low
$1.77
50-day MA
$2.87
200-day MA
$2.69
Beta
1.61

Analyst view

Analysts rate Goodrx Holdings Inc a buy (8 buy, 7 hold, 1 sell out of 16) with an average price target of $3.21.

Shareholding

Insiders
12.95%
Institutions
56.13%

Largest institutional holders

FundStake
Francisco Partners Management LP17.74%
LSV Asset Management1.47%
Ameriprise Financial Inc1.32%
Vanguard Capital Management, LLC1.26%
SILVER LAKE GROUP, L.L.C.1.04%
Vanguard Portfolio Management, LLC0.99%
Renaissance Technologies Corp0.96%
Petrus Trust Company, LTA0.91%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Goodrx Holdings Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.